Image 1_Metabolic consequences of erastin-induced ferroptosis in human ovarian cancer cells: an untargeted metabolomics study.pdf by Kaylie I. Kirkwood-Donelson (19697360)

“…Our study also found significant decreases in cellular taurine, a natural antioxidant in cells. …”

Data Sheet 1_Metabolic consequences of erastin-induced ferroptosis in human ovarian cancer cells: an untargeted metabolomics study.xlsx by Kaylie I. Kirkwood-Donelson (19697360)

“…Our study also found significant decreases in cellular taurine, a natural antioxidant in cells. …”

Data Sheet 1_Aronia melanocarpa L. fruit peels show anti-cancer effects in preclinical models of breast carcinoma: The perspectives in the chemoprevention and therapy modulation.do... by Dana Dvorska (19809111)

“…In the same tumors, we noted a significant dose-dependent decrease in the mitotic activity index compared to the control. …”

Data Sheet 1_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.xlsx by Minyong Choi (22465405)

“…Early sampling of within one month after treatment completion (≤ median 15 days) showed prognostic significance (pooled hazard ratios 3.43–3.55; p < 0.0001), whereas late sampling demonstrated no significant associations. …”

Image 8_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.tiff by Minyong Choi (22465405)

“…Early sampling of within one month after treatment completion (≤ median 15 days) showed prognostic significance (pooled hazard ratios 3.43–3.55; p < 0.0001), whereas late sampling demonstrated no significant associations. …”

Image 1_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.tiff by Minyong Choi (22465405)

“…Early sampling of within one month after treatment completion (≤ median 15 days) showed prognostic significance (pooled hazard ratios 3.43–3.55; p < 0.0001), whereas late sampling demonstrated no significant associations. …”

Image 7_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.tiff by Minyong Choi (22465405)

“…Early sampling of within one month after treatment completion (≤ median 15 days) showed prognostic significance (pooled hazard ratios 3.43–3.55; p < 0.0001), whereas late sampling demonstrated no significant associations. …”

Data Sheet 2_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.zip by Minyong Choi (22465405)

“…Early sampling of within one month after treatment completion (≤ median 15 days) showed prognostic significance (pooled hazard ratios 3.43–3.55; p < 0.0001), whereas late sampling demonstrated no significant associations. …”

Table 1_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.docx by Minyong Choi (22465405)

“…Early sampling of within one month after treatment completion (≤ median 15 days) showed prognostic significance (pooled hazard ratios 3.43–3.55; p < 0.0001), whereas late sampling demonstrated no significant associations. …”

Image 4_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.tiff by Minyong Choi (22465405)

“…Early sampling of within one month after treatment completion (≤ median 15 days) showed prognostic significance (pooled hazard ratios 3.43–3.55; p < 0.0001), whereas late sampling demonstrated no significant associations. …”

Image 3_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.tiff by Minyong Choi (22465405)

“…Early sampling of within one month after treatment completion (≤ median 15 days) showed prognostic significance (pooled hazard ratios 3.43–3.55; p < 0.0001), whereas late sampling demonstrated no significant associations. …”

Image 2_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.tiff by Minyong Choi (22465405)

“…Early sampling of within one month after treatment completion (≤ median 15 days) showed prognostic significance (pooled hazard ratios 3.43–3.55; p < 0.0001), whereas late sampling demonstrated no significant associations. …”

Image 5_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.tiff by Minyong Choi (22465405)

“…Early sampling of within one month after treatment completion (≤ median 15 days) showed prognostic significance (pooled hazard ratios 3.43–3.55; p < 0.0001), whereas late sampling demonstrated no significant associations. …”

Image 6_Can posttreatment blood inflammatory markers predict poor survival in gynecologic cancer?: a systematic review and meta-analysis.tif by Minyong Choi (22465405)

“…Early sampling of within one month after treatment completion (≤ median 15 days) showed prognostic significance (pooled hazard ratios 3.43–3.55; p < 0.0001), whereas late sampling demonstrated no significant associations. …”

Table 1_Health care resource use and costs associated with adult pneumococcal disease in the United States from 2017 to 2019, stratified by age and health risk: a retrospective coh... by Nicole Cossrow (473898)

“…Background<p>Adult pneumococcal disease (PD) represents a significant clinical and economic burden in the United States. …”

Supplementary file 1_HuangLian-4 alleviates myocardial ischemia-reperfusion injury by activating the pro-survival STAT3 signaling pathway.doc by Chelimuge Gong (22563287)

“…This activation of STAT3 was accompanied by a significant increase in the anti-apoptotic protein Bcl-2 and a decrease in pro-apoptotic Bax, alongside the suppression of the maladaptive factor HIF-1α. …”

Table 1_Effect of acarbose and vildagliptin on plasma trimethylamine N-oxide levels in patients with type 2 diabetes mellitus: a 6-month, two-arm randomized controlled trial.docx by Xinhui Yang (12051251)

“…Intragroup analysis indicated a significant decrease in TMAO levels at 6 months compared with baseline (adjusted p<0.05). …”

Table 3_Effect of acarbose and vildagliptin on plasma trimethylamine N-oxide levels in patients with type 2 diabetes mellitus: a 6-month, two-arm randomized controlled trial.docx by Xinhui Yang (12051251)

“…Intragroup analysis indicated a significant decrease in TMAO levels at 6 months compared with baseline (adjusted p<0.05). …”

Table 2_Effect of acarbose and vildagliptin on plasma trimethylamine N-oxide levels in patients with type 2 diabetes mellitus: a 6-month, two-arm randomized controlled trial.docx by Xinhui Yang (12051251)

“…Intragroup analysis indicated a significant decrease in TMAO levels at 6 months compared with baseline (adjusted p<0.05). …”

Data Sheet 1_mTOR promotes the formation and growth of tertiary lymphoid tissues in the kidney.docx by Daniel J. Atwood (21428960)

“…In summary, Torin2, which inhibited p-S6 in both tubules and TLTs, resulted in a large decrease in TLTs in ischemic and Pkd1^RC/RC kidneys. …”